Canada Outlines Requirements for Clinical Trial Applications
Sponsors seeking to import drugs into Canada for clinical trials must provide Health Canada with a “No Objection Letter” to facilitate shipment and demonstrate regulatory compliance, according to a Nov. 7 draft guidance on clinical trial applications (CTAs).
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.